
Companion Diagnostics Market Projected to Reach $11.57 Billion by 2031
The global companion diagnostics market is set for significant expansion, with projections indicating growth from $6.31 billion in 2026 to $11.57 billion by 2031. This trajectory, representing a compound annual growth rate of 12.9%, is fueled by the deepening integration of precision medicine and targeted oncology therapies into standard clinical practice.
























